Loading clinical trials...

Registry for Participants With Short Bowel Syndrome | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITING

Registry for Participants With Short Bowel Syndrome

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome

NCT01990040•Shire

Summary

This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for participants with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in participants with SBS. SBS participants treated and not treated with teduglutide will be enrolled.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Male and female participants, of any age, with a diagnosis of short bowel syndrome (SBS).
•2. Signed informed consent and medical records release by the participant or a legally acceptable representative
•3. Participants who have never received teduglutide treatment must be on parenteral nutrition (PN)/intravenous (IV) fluids support for at least 6 months at the time of enrollment.

Exclusion Criteria

•1. Participants currently participating in a blinded clinical trial or their extension studies.
•2. Participants who have never been on PN/IV support.
•3. Participants who are currently or previously exposed to any Glucagon-like peptide 2 (GLP-2) analogs other than teduglutide.

Locations (1)

Shire

Lexington, Massachusetts, United States

Key Dates

Start Date

June 23, 2014

Primary Completion Date

June 30, 2032

Completion Date

June 30, 2032

Last Updated

October 10, 2025

Enrollment

1,806

ACTUAL participants

Conditions

Short Bowel Syndrome

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

NCT07197944

Short Bowel Syndrome

View study

RECRUITING

A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)

NCT05561647

Short Bowel Syndrome (SBS)

View study

RECRUITINGPHASE3

A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

NCT06973304

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Registry for Participants With Short Bowel Syndrome

Inclusion Criteria

Exclusion Criteria

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)

A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF